BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 9627027)

  • 1. The delta32 deletion of CCR5 receptor in rheumatoid arthritis.
    Cooke SP; Forrest G; Venables PJ; Hajeer A
    Arthritis Rheum; 1998 Jun; 41(6):1135-6. PubMed ID: 9627027
    [No Abstract]   [Full Text] [Related]  

  • 2. Lack of association of C-C chemokine receptor 5 Δ32 deletion status with rheumatoid arthritis, systemic lupus erythematosus, lupus nephritis, and disease severity.
    Martens HA; Gross S; van der Steege G; Brouwer E; Berden JH; de Sevaux R; Derksen RH; Voskuyl AE; Berger SP; Navis GJ; Kallenberg CG; Bijl M
    J Rheumatol; 2010 Nov; 37(11):2226-31. PubMed ID: 20682662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of rheumatoid arthritis with a functional chemokine receptor, CCR5.
    Gómez-Reino JJ; Pablos JL; Carreira PE; Santiago B; Serrano L; Vicario JL; Balsa A; Figueroa M; de Juan MD
    Arthritis Rheum; 1999 May; 42(5):989-92. PubMed ID: 10323455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CC chemokine receptor 5 polymorphism in rheumatoid arthritis.
    Garred P; Madsen HO; Petersen J; Marquart H; Hansen TM; Freiesleben Sørensen S; Volck B; Svejgaard A; Andersen V
    J Rheumatol; 1998 Aug; 25(8):1462-5. PubMed ID: 9712084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of CCR5 Delta32 bp deletion in RA and SLE.
    Martens HA; Kallenberg CG; Bijl M
    Autoimmunity; 2009 May; 42(4):260-2. PubMed ID: 19811270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative association between the chemokine receptor CCR5-Delta32 polymorphism and rheumatoid arthritis: a meta-analysis.
    Prahalad S
    Genes Immun; 2006 Apr; 7(3):264-8. PubMed ID: 16541097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for negative association of the chemokine receptor CCR5 d32 polymorphism with rheumatoid arthritis.
    Pokorny V; McQueen F; Yeoman S; Merriman M; Merriman A; Harrison A; Highton J; McLean L
    Ann Rheum Dis; 2005 Mar; 64(3):487-90. PubMed ID: 15331395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 32-base pair deletion of the chemokine receptor 5 gene (CCR5-Delta32) is not associated with primary sclerosing cholangitis in 363 Scandinavian patients.
    Melum E; Karlsen TH; Broomé U; Thorsby E; Schrumpf E; Boberg KM; Lie BA
    Tissue Antigens; 2006 Jul; 68(1):78-81. PubMed ID: 16774544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential CCR5Delta32 allelic frequencies in juvenile idiopathic arthritis subtypes: evidence for different regulatory roles of CCR5 in rheumatological diseases.
    Scheibel I; Veit T; Neves AG; Souza L; Prezzi S; Machado S; Kohem C; Icarelli M; Xavier R; Brenol JC; Chies JA
    Scand J Rheumatol; 2008; 37(1):13-7. PubMed ID: 18189189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The chemokine receptor CCR5 genetic polymorphism and expression in rheumatoid arthritis patients.
    Kohem CL; Brenol JC; Xavier RM; Bredemeier M; Brenol CV; Dedavid e Silva TL; de Castilhos Mello A; Cañedo AD; Neves AG; Chies JA
    Scand J Rheumatol; 2007; 36(5):359-64. PubMed ID: 17963165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemokine receptor CCR2/CCR5 polymorphism in Spanish patients with systemic lupus erythematosus.
    Aguilar F; Núñez-Roldán A; Torres B; Wichmann I; Sánchez-Román J; González-Escribano MF
    J Rheumatol; 2003 Aug; 30(8):1770-4. PubMed ID: 12913933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCR5 (chemokine receptor-5) DNA-polymorphism influences the severity of rheumatoid arthritis.
    Zapico I; Coto E; Rodríguez A; Alvarez C; Torre JC; Alvarez V
    Genes Immun; 2000; 1(4):288-9. PubMed ID: 11196706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of association between the chemokine receptor 5 polymorphism CCR5delta32 in rheumatoid arthritis and juvenile idiopathic arthritis.
    Lindner E; Nordang GB; Melum E; Flatø B; Selvaag AM; Thorsby E; Kvien TK; Førre OT; Lie BA
    BMC Med Genet; 2007 Jun; 8():33. PubMed ID: 17565662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The chemokine receptor CCR5-Delta32 gene mutation is not protective against Alzheimer's disease.
    Combarros O; Infante J; Llorca J; Peña N; Fernández-Viadero C; Berciano J
    Neurosci Lett; 2004 Aug; 366(3):312-4. PubMed ID: 15288441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCR5 Delta32 deletion and atopic asthma in India.
    Batra J; Sharma M; Chatterjee R; Sharma S; Mabalirajan U; Ghosh B
    Thorax; 2005 Jan; 60(1):85. PubMed ID: 15618591
    [No Abstract]   [Full Text] [Related]  

  • 16. Distribution of the HIV resistance CCR5-Delta32 allele among Egyptians and Syrians.
    Salem AH; Batzer MA
    Mutat Res; 2007 Mar; 616(1-2):175-80. PubMed ID: 17166523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variation in CCR5 does not predict clinical outcome in inflammatory arthritis.
    John S; Smith S; Morrison JF; Symmons D; Worthington J; Silman A; Barton A
    Arthritis Rheum; 2003 Dec; 48(12):3615-6. PubMed ID: 14674019
    [No Abstract]   [Full Text] [Related]  

  • 18. The chemoattraction of lymphocytes by rheumatoid arthritis - synovial fluid is not dependent on the chemokine receptor CCR5.
    Santiago B; Galindo M; Rivero M; Brehmer MT; Mateo I; Pablos JL
    Rheumatol Int; 2002 Jul; 22(3):107-11. PubMed ID: 12111085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCR5-Delta32 mutation is strongly associated with primary sclerosing cholangitis.
    Eri R; Jonsson JR; Pandeya N; Purdie DM; Clouston AD; Martin N; Duffy D; Powell EE; Fawcett J; Florin TH; Radford-Smith GL
    Genes Immun; 2004 Sep; 5(6):444-50. PubMed ID: 15215889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of CCR5-Delta32 deletion in human immunodeficiency virus type 1 (HIV-1) in healthy blood donors, HIV-1-exposed seronegative and HIV-1-seropositive individuals of southern Brazilian population.
    Reiche EM; Ehara Watanabe MA; Bonametti AM; Morimoto HK; Akira Morimoto A; Wiechmann SL; Matsuo T; Carvalho De Oliveira J; Vissoci Reiche F
    Int J Mol Med; 2008 Nov; 22(5):669-75. PubMed ID: 18949389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.